Bicocca Open Archive

Logo unimib boa
CRISTOFERI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.025
AS - Asia 4.376
EU - Europa 3.909
SA - Sud America 699
AF - Africa 117
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 15.132
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.716
SG - Singapore 1.471
IT - Italia 1.331
CN - Cina 785
VN - Vietnam 758
HK - Hong Kong 608
RU - Federazione Russa 554
BR - Brasile 516
DE - Germania 480
SE - Svezia 453
IE - Irlanda 266
CA - Canada 230
GB - Regno Unito 223
IN - India 157
FR - Francia 153
BD - Bangladesh 94
KR - Corea 89
AR - Argentina 75
ID - Indonesia 64
FI - Finlandia 63
NL - Olanda 61
ES - Italia 51
TR - Turchia 50
CH - Svizzera 48
IQ - Iraq 46
AT - Austria 40
UA - Ucraina 39
ZA - Sudafrica 37
MX - Messico 35
PK - Pakistan 34
MY - Malesia 33
PL - Polonia 29
JP - Giappone 28
PH - Filippine 26
EC - Ecuador 25
DK - Danimarca 23
SA - Arabia Saudita 23
CO - Colombia 22
VE - Venezuela 22
UZ - Uzbekistan 19
BE - Belgio 17
IL - Israele 14
LT - Lituania 14
CL - Cile 13
MA - Marocco 13
PY - Paraguay 13
JM - Giamaica 12
KE - Kenya 12
EG - Egitto 11
ET - Etiopia 10
JO - Giordania 10
PT - Portogallo 9
TN - Tunisia 9
TW - Taiwan 8
AZ - Azerbaigian 7
GR - Grecia 7
RS - Serbia 7
CZ - Repubblica Ceca 6
NO - Norvegia 6
SK - Slovacchia (Repubblica Slovacca) 6
SY - Repubblica araba siriana 6
BO - Bolivia 5
CR - Costa Rica 5
DZ - Algeria 5
NP - Nepal 5
PA - Panama 5
BA - Bosnia-Erzegovina 4
HN - Honduras 4
KZ - Kazakistan 4
MM - Myanmar 4
PE - Perù 4
RO - Romania 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
GD - Grenada 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
MU - Mauritius 3
OM - Oman 3
PS - Palestinian Territory 3
SN - Senegal 3
UY - Uruguay 3
AL - Albania 2
AU - Australia 2
CG - Congo 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
GA - Gabon 2
GE - Georgia 2
GH - Ghana 2
HR - Croazia 2
IR - Iran 2
KH - Cambogia 2
MO - Macao, regione amministrativa speciale della Cina 2
NI - Nicaragua 2
SV - El Salvador 2
TH - Thailandia 2
TJ - Tagikistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 15.104
Salva come PNG Salva come JPEG
Città #
Singapore 907
Ann Arbor 862
Hong Kong 587
Ashburn 537
San Jose 505
Milan 429
Frankfurt am Main 369
Dublin 252
Fairfield 231
Chicago 228
Chandler 220
New York 214
Ho Chi Minh City 211
Los Angeles 186
Toronto 185
Wilmington 181
Hanoi 179
Hefei 153
Beijing 132
Santa Clara 120
Dallas 111
Rome 110
The Dalles 108
Woodbridge 104
Seattle 100
London 99
Houston 95
Boardman 87
Seoul 84
Cambridge 81
Princeton 72
Lauterbourg 71
Shanghai 68
Buffalo 65
São Paulo 58
Council Bluffs 54
Dearborn 44
Moscow 44
Jakarta 43
Zurich 43
Helsinki 42
Lawrence 35
Florence 33
Orem 33
Munich 32
Monza 31
Denver 29
Altamura 28
Haiphong 26
Tokyo 25
Turin 25
Warsaw 25
Da Nang 24
San Diego 21
Chennai 20
Johannesburg 20
Naples 20
Pune 20
Montreal 19
Rio de Janeiro 19
Ninh Bình 18
Nuremberg 18
Atlanta 17
Biên Hòa 17
Can Tho 17
Mumbai 17
Tashkent 17
Bologna 16
Brussels 16
Nanjing 16
Paris 16
Penang 16
Poplar 16
Vienna 16
New Delhi 15
Baghdad 14
Brooklyn 14
Jacksonville 14
Salt Lake City 14
Columbus 13
Elk Grove Village 13
Modena 13
Phoenix 13
Stockholm 13
Andover 12
Bari 12
Genoa 12
Hải Dương 12
Istanbul 12
Amsterdam 11
Boston 11
Campinas 11
Guarulhos 11
Ha Long 11
Lappeenranta 11
Mexico City 11
Nairobi 11
Cairo 10
Detroit 10
Jeddah 10
Totale 9.303
Salva come PNG Salva come JPEG
Nome #
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 597
Quality of life in patients with primary biliary cholangitis: a cross-geographical comparison 416
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 388
Endocrinology and Metabolic Diseases (Including Diabetes) 348
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 345
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 342
Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis 340
Risk stratification in primary sclerosing cholangitis 335
Precision medicine in primary biliary cholangitis 332
FRI-008-Incidence, prevalence and mortality of primary sclerosing cholangitis in Italy: A population-based study 321
Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach 321
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 318
Additive beneficial effects of Fibrates combined with Obeticholic acid in the treatment of patients with Primary Biliary Cholangitis and inadequate response to second-line therapy: data from the Italian PBC Study Group 300
A NOVEL MACHINE-LEARNING, COMMON VARIANTS-BASED APPROACH TO PREDICT PRIMARY BILIARY CHOLANGITIS 294
Machine learning in primary biliary cholangitis: A novel approach for risk stratification 288
THU-010-Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 287
New Therapeutic Targets in Autoimmune Cholangiopathies 286
Clinical treatment of cholangiocarcinoma: an updated comprehensive review 273
RADIOLOGY-BASED BIOMARKERS DISCOVERY IN PRIMARY SCLEROSING CHOLANGITIS: FROM RISK STRATIFICATION TO THE EVALUATION OF TREATMENT BENEFIT 261
Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies 258
Ductular reaction, intermediate hepatocytes and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 256
Primary biliary cholangitis: a multifaceted pathogenesis with potential therapeutic targets 253
Prognostic models in primary biliary cholangitis 249
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 244
Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients 242
FRI-011-Ductular reaction, intermediate hepatocites and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 240
Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain? 239
Artificial intelligence for precision medicine in autoimmune liver disease 238
Improving predictive accuracy in primary biliary cholangitis: A new genetic risk score 234
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 228
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 228
Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study 225
Fibrocystic liver disease 224
Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis 222
Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement 216
COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy 214
X marks the spot in autoimmunity 210
Primary sclerosing cholangitis: Burden of disease and mortality using data from the national rare diseases registry in Italy 210
The immunobiology of female predominance in primary biliary cholangitis 207
Non-invasive imaging biomarkers in chronic liver disease 203
An update on novel pharmacological agents for primary sclerosing cholangitis 198
Comment on "Early Prognostic Utility of Gp210 Antibody-Positive Rate in Primary Biliary Cholangitis: A Meta-Analysis" 186
Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat 184
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis 179
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis 177
LLM-PBC: Logic Learning Machine-Based Explainable Rules Accurately Stratify the Genetic Risk of Primary Biliary Cholangitis 176
European Society for Organ Transplantation (ESOT) Consensus Statement on Outcome Measures in Liver Transplantation According to Value-Based Health Care 174
The Role of Epigenetics in Primary Biliary Cholangitis 169
Geoepidemiology and (epi-)genetics in primary biliary cholangitis 167
The Time is Ripe for a Randomized Controlled Trial of Oral Vancomycin in Primary Sclerosing Cholangitis 165
A Smooth Esophageal Stricture Causing Dysphagia 165
Individualizing Care: Management Beyond Medical Therapy 159
Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 157
Prevalence of upper gastrointestinal endoscopic findings in the community: A systematic review of studies in unselected samples of subjects 155
Takayasu arteritis and primary sclerosing cholangitis: A casual association or different phenotypes of the same disease? 153
EFFICACY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS-AUTOIMMUNE HEPATITIS OVERLAP PATIENTS WITH PERSISTENTLY ELEVATED TRANSAMINASES DESPITE IMMUNOSUPPRESSION 147
Diagnostic Yield of Whole Exome Sequencing in Adult-onset Cholestatic Liver Disease 145
Antioxidant treatment for acute pancreatitis 142
Pre-treatment risk stratification in primary biliary cholangitis: A predictive model to guide first-line combination therapy 140
Systematic review-Pancreatic involvement in inflammatory bowel disease 139
Glycomic analysis of antibody indicates distinctive glycosylation profile in patients with autoimmune cholangitis 139
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis 124
Anti-gp210 and other anti-nuclear pore complex autoantibodies in primary biliary cholangitis: What we know and what we should know 115
Primary Sclerosing Cholangitis 114
Cluster analysis reveals the prognostic role of serum albumin within the normal range in patients with primary biliary cholangitis 110
Elastography in Autoimmune Liver Diseases 108
Transient elastography in chronic liver disease: beware to the cut-offs! 106
Individualizing Care: Management Beyond Medical Therapy 103
Clustering Reveals the Prognostic Role of Serum Albumin Values Within the Normal Range in Patients with Primary Biliary Cholangitis 66
Totale 15.494
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.942
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.942
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022772 100 98 140 80 43 41 14 42 39 32 53 90
2022/20231.439 118 329 125 93 152 181 108 69 101 47 76 40
2023/20241.363 45 65 67 134 145 271 181 28 69 98 45 215
2024/20252.845 195 303 153 143 233 130 191 111 302 421 260 403
2025/20267.138 934 531 494 770 683 346 1.046 309 519 597 411 498
2026/202749 49 0 0 0 0 0 0 0 0 0 0 0
Totale 15.494